Anshu Giri, MD, MS

​​
This physician is not currently rated. Why?

Why is this doctor not rated?

Close

To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings
Request an Appointment

Call 888-369-2427

Request Online

Clinical Locations

Chief, General Hematology/Oncology

Assistant Professor, Department of Hematology/Oncology

Oncology Informatics Physician Lead

Specialties

Key Awards

2023 top doctors
Medical Oncology

Treatment Philosophy

For a cancer patient the ideal treatment maximizes quality of life, while minimizing side effects. My philosophy as an oncologist is to guide the patient toward achieving this goal. I strive to ensure that patients and their families have a comprehensive understanding of their disease and available treatment options. In addition, I believe a patient deserves to be treated functionally, emotionally, and socially, as a whole person. By being a part of Fox Chase Cancer Center, I will be working with a team devoted to making this happen.

After completing my fellowship at the Medical University of South Carolina, I am excited to join Fox Chase and the vibrant medical community in Philadelphia. I was immediately impressed by the collegiality of the faculty and staff, as well as the multidisciplinary approach to their care. I am enthusiastic about being involved in the treatment of a variety of solid tumors.
 

Educational Background

  • Hematology Oncology Fellowship, Medical University of South Carolina, Charleston, SC, 2016-2019
  • Internal Medicine Residency, Upstate Medical University, Syracuse, NY, 2013-2016
  • MD, St. George’s University, Grenada, 2009-2013
  • MS, Medical Sciences, Wayne State University, Detroit, MI, 2006-2008
  • BS, Chemistry, University of Michigan, Ann Arbor, MI, 2003-2006

Certifications

  • American Board of Internal Medicine, 2016
  • American Board of Medical Oncology, 2019
  • American Board of Hematology, 2019
  • BLS and ACLS

Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2023-2024
Lisa Shustack

Lisa Shustack

  • Breast Cancer

A few years ago, when I was 46, something unusual showed up on my yearly mammogram. So they did an ultrasound and said I should come back every six months for monitoring for the next two years.

For 18 months, there was no change. Then, in April of 2023, I went for my last follow-up scan. When we finished, instead of sending me home, the radiologist came into the room to talk to me. I knew then that something wasn’t right.

She said there had been a change since my last scan. It looked like I had a malignancy in my right breast, and we would need a biopsy to be sure.

VIEW PATIENT STORY

Selected Publications

Giri, A., Walia, SS., Gajra, A. Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer. Rev Recent Clin Trials. 2016, Jul 24.

Pinto, I., Giri, A., Arshad, U., Gajra, A. New Oral Anticoagulants and Their Reversal. Current Drug Safety. 2015; 10 (3): 208-16.

Aleksiejuk, P., Pawar, L., Giri, A.. Conservative Management of Spontaneous Esophageal Perforation in a Patient with Achalasia. Critical Care Medicine. 2014, Dec; 42(12): A1660.

Giri, A., Goustin, A.S., Wang, S., Al-Katib, A., Mohammad, R.. Surface plasmon resonance study of apoptotic regulators Bcl-2, Bcl-w, Bcl-XL, Mcl-1 and A1 and the small molecule inhibitor (SMI) TW-37: the idea of a temporal window for drug activity. Cancer Research. 2008, May; 68(9S): 3192.

Mohammad, R., Giri, A., Goustin, A. S.. Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer. Recent patents on anti-cancer drug discovery. 2008, Jan; 3(1): 20-30.

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...
​​
Resize Text

Related Articles